Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 7
2008 5
2009 3
2010 8
2011 12
2012 12
2013 22
2014 17
2015 31
2016 31
2017 36
2018 31
2019 36
2020 30
2021 26
2022 21
2023 39
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

337 results

Results by year

Filters applied: . Clear all
Page 1
Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysis.
Levinsson A, Zolopa C, Vakili F, Udhesister S, Kronfli N, Maheu-Giroux M, Bruneau J, Valerio H, Bajis S, Read P, Martró E, Boucher L, Morris L, Grebely J, Artenie A, Stone J, Vickerman P, Larney S. Levinsson A, et al. Among authors: grebely j. EClinicalMedicine. 2024 Apr 10;72:102596. doi: 10.1016/j.eclinm.2024.102596. eCollection 2024 Jun. EClinicalMedicine. 2024. PMID: 38633576 Free PMC article.
Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage study.
Valerio H, Marshall AD, Conway A, Treloar C, Carter L, Martinello M, Henderson C, Amin J, Read P, Silk D, Degenhardt L, Prain B, Alavi M, Dore GJ, Grebely J; ETHOS Engage Study Group. Valerio H, et al. Among authors: grebely j. Int J Drug Policy. 2024 Apr 11;127:104394. doi: 10.1016/j.drugpo.2024.104394. Online ahead of print. Int J Drug Policy. 2024. PMID: 38608357 Free article.
96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial.
Farrell M, Shahbazi J, Chambers M, Byrne M, Gholami J, Zahra E, Grebely J, Lintzeris N, Larance B, Ali R, Nielsen S, Dunlop A, Dore GJ, McDonough M, Montebello M, Weiss R, Rodgers C, Cook J, Degenhardt L; CoLAB study team. Farrell M, et al. Among authors: grebely j. Int J Drug Policy. 2024 Mar 23;127:104390. doi: 10.1016/j.drugpo.2024.104390. Online ahead of print. Int J Drug Policy. 2024. PMID: 38522175 Free article.
Vaccination coverage among people who inject drugs: A systematic review.
Price O, Swanton R, Grebely J, Hajarizadeh B, Webb P, Peacock A, Dore GJ, Cowie BC, Vickerman P, Degenhardt L. Price O, et al. Among authors: grebely j. Int J Drug Policy. 2024 Mar 18;127:104382. doi: 10.1016/j.drugpo.2024.104382. Online ahead of print. Int J Drug Policy. 2024. PMID: 38503233 Free article. Review.
Health utility among people who regularly use opioids in Australia.
Tran AD, Grebely J, Chambers M, Degenhardt L, Farrell M, Bajis S, Larance B. Tran AD, et al. Among authors: grebely j. Drug Alcohol Rev. 2024 May;43(4):997-1012. doi: 10.1111/dar.13823. Epub 2024 Feb 25. Drug Alcohol Rev. 2024. PMID: 38403293
337 results